Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: The Uganda NOHARM sickle cell anemia cohort

Robert O. Opoka, Heather A. Hume, Teresa S. Latham, Adam Lane, Olatundun Williams, Jennifer Tymon, Maria Nakafeero, Phillip Kasirye, Christopher M. Ndugwa, Chandy C. John, Russell E. Ware*

*Corresponding author for this work

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)E272-E275
JournalHaematologica
Volume105
Issue number6
DOIs
StatePublished - Jun 1 2020

ASJC Scopus subject areas

  • Hematology

Cite this

Opoka, R. O., Hume, H. A., Latham, T. S., Lane, A., Williams, O., Tymon, J., Nakafeero, M., Kasirye, P., Ndugwa, C. M., John, C. C., & Ware, R. E. (2020). Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: The Uganda NOHARM sickle cell anemia cohort. Haematologica, 105(6), E272-E275. https://doi.org/10.3324/haematol.2019.231407